معرفی
Kristen Marks is an Associate Professor of Medicine at Weill Cornell Medical College within Cornell University. Her clinical expertise spans HIV/AIDS, Viral Hepatitis, and Long COVID, with active roles at the Weill Cornell Clinical Trials Unit and the Center for Special Studies (HIV/AIDS). She leads studies on HIV/HCV co-infection, hepatitis B/C vaccines, and substance use disorders.
- Education:
- M.S. in Clinical Investigation, Weill Cornell Graduate School (2009)
- M.D., Columbia University (1999)
- B.A./M.S., Stanford University (1995)
Her research focuses on improving treatment outcomes for HIV/viral hepatitis co-infections, particularly among people who inject drugs (PWID). She has pioneered accessible care models at syringe exchange programs and led AIDS Clinical Trials Group (ACTG) initiatives. Recent work addresses Long COVID and hepatitis B vaccine development for immunocompromised populations.
Key publications highlight her work on direct-acting antivirals for HCV, rapid treatment initiation, and vaccine efficacy in HIV+ individuals. Her studies often intersect public health policy with clinical practice guidelines, reflecting a commitment to optimizing care for marginalized communities.
She co-chaired the IDSA/AASLD Hepatitis C Guidelines Panel and served on New York State’s HCV guidelines, while her teaching roles span medical students, residents, and fellows. Collaborations with organizations like Gilead Sciences and Novo Nordisk underscore her translational research impact.
